Marketing & Strategy
Customer-Centric Engagement During COVID-19

Navigating the multichannel maze in COVID 19 times to engage healthcare professionals (HCPs) and patients has been challenging for most local marketing, medical and commercial teams.
In the last few weeks, Health Industry Hub gained insights from several clinicians (GPs, specialists and surgeons) on how the COVID-19 pandemic has impacted their day-to-day world in clinics and with their patients. See infographic below.
In overwhelming times, most HCPs are not looking to engage with the field force in one-on-one virtual meetings or phone calls unless there is a compelling reason to do so, for example, clinical trials, virtual advisory boards, new registration / reimbursement of medicines or medical devices.
Instead, HCPs are interested in receiving valuable, cross-functional medical content that is easy to access and is of benefit to them and/or their patients.
Click on the image below to learn more.

Customer engagement during COVID-19. Fill the gap of reduced field force activities. Health Industry Hub combines expertise in delivering digital health content and measuring engagement with 20+ years industry experience. Created by industry for industry. Contact us.
News - Pharmaceuticals
New vaccine guidelines risk further decline in immunisation
The intensifying political and public scrutiny of Dr Anthony Fauci has become emblematic of a wider struggle over trust in […]
MoreNews - Pharmaceuticals
The weight of the wait: GLP-1 boom hits PBS roadblock
More than one million Australians have been dispensed a GLP-1 receptor agonist over the past five years, accelerating the emergence […]
MoreNews - MedTech & Diagnostics
As insurer blame game escalates, patients miss out on the promise of private health
The Age and Sydney Morning Herald’s investigation into the Prescribed List (PL) and the pricing of medical devices has drawn […]
MoreLeadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
More